Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
26,223,257
-
Share change
-
+3,319,433
-
Total reported value
-
$190,116,906
-
Price per share
-
$7.25
-
Number of holders
-
54
-
Value change
-
+$24,381,282
-
Number of buys
-
37
-
Number of sells
-
10
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q4 2017
As of 31 Dec 2017,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,223,257 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, Vivo Capital, LLC, BlackRock Inc., Lyon Street Capital, LLC, Opaleye Management Inc., Tredje AP-fonden, and Granite Point Capital Management, L.P..
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.